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Residual endotoxin induces primary graft dysfunction
through ischemia/reperfusion-primed alveolar
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Despite the widespread use of antibiotics, bacterial pneumonias in donors strongly predispose to the fatal syndrome of
primary graft dysfunction (PGD) following lung transplantation. We report that bacterial endotoxin persists in human donor
lungs after pathogen is cleared with antibiotics and is associated with neutrophil infiltration and PGD. In mouse models,
depletion of tissue-resident alveolar macrophages (TRAMs) attenuated neutrophil recruitment in response to endotoxin as
shown by compartmental staining and intravital imaging. Bone marrow chimeric mice revealed that neutrophils were recruited
by TRAM through activation of TLR4 in a MyD88-dependent manner. Intriguingly, low levels of endotoxin, insufficient to
cause donor lung injury, promoted TRAM-dependent production of CXCL2, increased neutrophil recruitment, and led to PGD,
which was independent of donor NCMs. Reactive oxygen species (ROS) increased in human donor lungs starting from the
warm-ischemia phase and were associated with increased transcription and translocation to the plasma membrane of TLR4
in donor TRAMs. Consistently, scavenging ROS or inhibiting their production to prevent TLR4 transcription/translocation
or blockade of TLR4 or coreceptor CD14 on donor TRAMs prevented neutrophil recruitment in response to endotoxin and
ameliorated PGD. Our studies demonstrate that residual endotoxin after successful treatment of donor bacterial pneumonia
promotes PGD through ischemia/reperfusion-primed donor TRAMs.

Introduction

Prolonged mechanical ventilation, aspiration of gastric contents
into the lungs around the time of death, and immune dysfunction after brain death all contribute to increased rates of bacterial
infections in donor lungs (1, 2). Despite the routine use of bronchoalveolar lavage culture and empiric and pathogen-directed
antimicrobial therapy, the presence of bacteria in donor lungs
is associated with increased risk for primary graft dysfunction
(PGD), the predominant cause of mortality following lung transplantation (3). These high rates of bacterial recovery and the associated PGD following transplant are major reasons why donor
lungs have a utilization rate of only about 15%, which is one of
the lowest among all solid organs (www.unos.org). The low utilization of donor lungs accounts for the high mortality and long
wait times observed in patients requiring lung transplantation.
How bacteria in the donor lungs predispose to the pathogenesis
of PGD and why antimicrobial therapy is unable to prevent lung
allograft injury remains unclear.
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Host neutrophils recruited to the lung allograft mediate lung
ischemia/reperfusion injury leading to PGD, the most important risk factor for early and chronic allograft failure, but are also
necessary for the clearance of bacterial and fungal pathogens
(4–13). Since neutrophil depletion is unlikely to be tolerated in
immunosuppressed lung transplant patients, it is critical to delineate mechanisms leading to neutrophil recruitment immediately
after transplant. The severity of neutrophil recruitment and the
resulting PGD varies dramatically among lung transplant recipients. Because broad-spectrum antibiotics targeting most Gramnegative organisms are routinely administered to both the donor
and recipient before transplantation, the role of bacteria in the
donor lung in driving this heterogeneity has been overlooked.
Surprisingly, we detected lipopolysaccharide (LPS), also
referred to as endotoxin, in human donor lungs with bacterial
pathogens before transplant, despite antibiotic therapy. LPS is a
prototypical pathogen-associated molecular pattern (PAMP) in
the outer cytoplasmic membrane of Gram-negative bacteria that
signals through TLR4 receptors to induce neutrophil influx into
the alveolar space (4, 14). We recently discovered that donor origin
pulmonary intravascular nonclassical monocytes (NCMs) trigger
neutrophil recruitment following lung transplantation through the
production of neutrophil chemoattractant CXCL2 (11, 13, 15). The
donor NCMs also recruit spleen-derived CCR2+ classical mono-

RESEARCH ARTICLE

The Journal of Clinical Investigation  

Figure 1. Persistence of endotoxin in human and murine donor lungs is associated with neutrophil influx and PGD following transplantation. (A)
Human donor lungs with microbial cultures positive for Gram-negative bacteria were treated with antimicrobials, resulting in clearance of the pathogen
at the time of transplantation. To test for persistence of endotoxin, BALF serially obtained from the same patient was analyzed (n = 9). (B) Human donor
lungs from endotoxin-negative and endotoxin-positive lungs were analyzed for tissue neutrophil infiltration before reperfusion and 30 minutes after
reperfusion using intraoperative lung biopsy of the inferior lingular segment (n = 10). (C) To determine the function of the lung allograft, we obtained
blood directly from the pulmonary vein confluence immediately proximal to the site of venous anastomosis and analyzed partial pressure of oxygen (PaO2
mmHg) before and after reperfusion. The PaO2 to fractional inspired oxygen (FiO2) ratio (P/F ratio) was then calculated for lungs negative and positive for
endotoxin (n = 12). (D) Donor mice were administered a low dose of LPS i.t. (E. coli [0.5 μg/g BW], P. aeruginosa [0.2 μg/g BW], and K. pneumoniae [0.2
μg/g BW]), insufficient to cause injury in native lung, and then lungs were transplanted into allogeneic recipients. The neutrophil infiltration was then
analyzed following transplant (n = 3–6). Graphs show mean ± SD. Graphs were analyzed by unpaired t test. *P < 0.05; **P < 0.01; ****P < 0.0001.

cytes (CMs) to the allograft, which contribute to neutrophil extravasation, worsening lung injury (12). Thus, both donor-derived
NCMs and recipient CMs play complementary roles in neutrophil
recruitment and extravasation to initiate lung transplant ischemia/
reperfusion injury. These mechanisms differ from observations
in naive mice treated with LPS in which tissue-resident alveolar
macrophages (TRAMs), or other cell populations in the lung, may
be necessary for neutrophil recruitment (16–19). We therefore
hypothesized that LPS from the different bacterial pathogens and
perhaps other PAMPs, persisting after successful antimicrobial
therapy, contribute to excessive neutrophil recruitment after lung
transplantation by augmenting signaling through NCMs or CMs,
and/or activated parallel pathways through TRAMs.
We found that endotoxin can persist in human donor lungs
despite pathogen clearance and is associated with increased
neutrophil infiltration and PGD after lung transplantation.
Pharmacologic and genetic depletion of donor NCMs attenuated neutrophil recruitment following transplant of naive donor
lungs (12, 13), but did not abrogate neutrophil recruitment and
PGD in donor lungs containing endotoxin. In addition, exposure of donor TRAMs to ischemia/reperfusion primed them
to release CXCL2 in response to endotoxin through a TLR4/
MyD88 pathway, obviating the requirement for donor NCMs in
neutrophil recruitment to the allograft. Donor lungs produced
reactive oxygen species (ROS), beginning in the warm-ischemia
phase, which led to both an increase in TLR4 transcription and
its translocation to the cell plasma membrane. Accordingly,
ROS scavengers, blockade of TLR4, or TLR4 coreceptor CD14
resulted in amelioration of PGD when endotoxin was present in
the donor lungs. Our results suggest that a multipronged strategy that targets both TRAMs and NCMs within the donor lung
can reduce the severity of PGD in donors with a history of bacterial pneumonia or colonization.

Results

Endotoxin persists in donor lung despite pathogen clearance, and
predisposes to PGD. Recruitment of host neutrophils to the lung
allograft following lung transplantation mediates lung ischemia/
reperfusion injury (10). To determine whether bacterial split products in the donor lung could exacerbate neutrophil influx after
transplant, we analyzed human donor lungs that were positive for
Gram-negative bacteria before transplant but treated with antimicrobials. These human donor lungs had normal P/F ratio in
the donor before transplant and no pulmonary infiltrates on chest
radiograph or computed tomography. Successful treatment of
the infection was evident by negative microbial cultures of bronchoalveolar fluid (BALF) collected at the time of transplantation.
However, as shown in Figure 1A, the BALF of successfully treated
human donor lungs obtained at transplant revealed residual endotoxin that persisted following transplantation. Intriguingly, following transplantation, these endotoxin-containing donor lungs
showed physiological markers of injury, including significantly
higher neutrophil infiltration as well as reduced P/F ratio after
transplant, compared with those without endotoxin (Figure 1, B
and C), although there was no significant difference in the neutrophil count and P/F ratio between the 2 groups in the donor before
lung procurement (Figure 1, B and C). We replicated these observations in a murine model of lung transplantation by administering intratracheal (i.t.) PBS control or a low dose of LPS from 3 different bacteria (0.5 μg/g BW E. coli, 0.2 μg/g BW P. aeruginosa or
0.2 μg/g BW K. pneumoniae) to donor mice before transplantation
into allogeneic murine recipients. The low dose was insufficient to
cause neutrophil infiltration or injury in the native lungs. However,
the grafts containing LPS experienced severe PGD at 24 hours,
which was associated with an increase in chemokines in the BALF
(Supplemental Figure 1; supplemental material available online
with this article; https://doi.org/10.1172/JCI135838DS1), includjci.org   Volume 130   Number 8   August 2020
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Figure 2. TRAMs upregulate CXCL2 in response
to endotoxin and pseudomonas. Transcriptomic
profiling of human TRAMs during Gram-negative bacterial pneumonia revealed upregulation
of CXCL2, a known neutrophil chemoattractant.
TRAMs were identified as CD15–HLA–DR+CD169+
CD206++, and flow sorted for RNA isolation,
library preparation, and sequencing (culturenegative, n = 4; P. aeruginosa–positive, n = 6). (A)
Heatmap of top 1000 most significantly differentially expressed genes ranked by FDR q value. Both
samples and genes are grouped by hierarchical
clustering. (B) Functional enrichment analysis with
GO biological processes was performed with GOrilla
with the top 1000 genes upregulated in P. aeruginosa–positive samples for all clusters. In total,
443 significantly upregulated genes were used
to identify the top 5 biological processes (–log10
[P value]). (C) Heatmap of pathway genes (750
genes) based on the top GO processes identified
in B (GO:0002376,GO:0019221, GO:0002237,GO:00
06954,GO:0006950). Hierarchical clustering shows
the expression of these genes in naive, low, and
high virulence samples for MISTRG mice. Selective
genes are highlighted (n = 3–4). (D) Normalized
CPM counts of CXCL2 in both human and MISTRG
mouse following infection with P. aeruginosa (n =
3–6). Graph show mean ± SD and was analyzed by
unpaired t test.**P < 0.01.

ing CXCL2, a potent neutrophil chemoattractant (13, 20), as well as
profound neutrophil influx (Figure 1D). These data suggested that
low levels of endotoxin may not cause clinically significant lung
injury; however, following ischemia/reperfusion, the susceptibility
of lung allografts to residual endotoxin increases substantially.
Finally, recent studies have suggested that the donor microbiome may play a role in the development of lung allograft rejection
(21–24). Since the role of the donor lung microbiome in the pathogenesis of PGD is uncertain, we analyzed the BALF from human
donor lungs by 16S PCR high-throughput screening, as previously
described (25, 26). BAL samples were distinct from rectal samples
(R = 0.977, P = 0.002), and no microbial clustering within BAL samples was apparent. PGD sample (patient 9) was not dissimilar from
non-PGD samples (patients 1–7, 8, 10) (R = –0.279, P = 0.625). There
was also no variation in the donor lung microbiome with regard to
endotoxin-containing organisms and this lack of variation is, therefore, unlikely to explain our results (Supplemental Figure 2).
CXCL2 secreted from TRAMs contributes to neutrophil recruitment and lung injury following bacterial infection or LPS administration. To determine the mechanisms by which endotoxin in
donor lungs accentuates PGD, we first studied the mechanism of
endotoxin-induced lung injury in the native mouse lung. Given
that LPS from all 3 bacterial species induced PGD and neutrophil
influx, for subsequent studies we used LPS from E. coli since it
has been used most commonly in published literature. Consistent
with prior reports, we found that 24 hours after high dose (2 μg/g
4458

jci.org   Volume 130   Number 8   August 2020

BW) i.t. LPS administration there was a robust neutrophil influx
(Supplemental Figure 3A) in native lungs with more than 80% of
neutrophil extravasated into the alveolar space (Supplemental Figure 3B). This was accompanied by pulmonary edema and histologic signs of injury (Supplemental Figure 3, C and D) (27, 28). We
then performed RNA-Seq analysis of flow-sorted TRAMs isolated
from BALF in patients with severe pneumonia resulting in respiratory failure in our medical intensive care unit (16). Specifically,
we compared alveolar macrophage transcriptomes from patients
with confirmed pneumonia secondary to Pseudomonas aeruginosa
(based on quantitative culture of the same BALF sample) to transcriptomes of patients with negative quantitative culture and
found that differentially expressed genes were associated with
gene ontology (GO) processes involved in immune activation (Figure 2, A and B). We found that those genes associated with the GO
processes in human subjects were also differentially expressed in
the TRAMs of humanized Rag–/– IL2g–/– mice with transgenes for
human GM-CSF and IL-3 (MISTRG mice) infected with Pseudomonas (Figure 2C). Furthermore, compared with those without pneumonia, TRAMs from patients with Pseudomonas pneumonia and
MISTRG mice infected with P. aeruginosa demonstrated a significant increase in the expression of the primary neutrophil chemokine, CXCL2 (Figure 2D), which we have shown to be pivotal in
neutrophil chemotaxis to the reperfused lung allograft (11, 13, 15).
To further investigate whether TRAMs were responsible for
CXCL2 production in response to LPS in TLR4-dependent manner,
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Figure 3. Influx of neutrophils into LPS-treated lung is abrogated by selective depletion of TRAMs. (A) CXCL2 chemokine levels in BALF of LPS-treated
mice injected with PBS-lip or Clo-lip i.t. (n = 5–6). (B) Quantification of neutrophil infiltration into lungs in TRAM-depleted compared with PBS-lip control
mice 24 hours after LPS administration (n = 6–11). Neutrophils were gated as live CD45+Ly6G+CD11b+CD24+SSChi cells. (C) Representative intravital 2-photon
microscopy images of control PBS-lip– or Clo-lip–treated lungs 4 hours after LPS administration in B6 LysM-GFP mice (also refer to Supplemental Videos
1 and 2). Q-dots (655-nm nontargeted) were injected 5 minutes before imaging to label the vessels red (n = 3). (D) Quantification of total GFP+ neutrophils
from C (n = 3). (E) Quantification of neutrophil infiltration into lungs in LPS-treated mice previously injected with IgG or an antibody against CXCL2 (n = 3–4).
(F) Quantification of neutrophil infiltration into lungs in LPS-treated mice in WT (WT) compared with Cxcr2–/– (Cxcr2.KO) mice (n = 3–6). Scale bar: 30 μm. All
graphs show mean ± SD. Graphs were analyzed by unpaired t test. *P < 0.05; **P < 0.01; ***P < 0.001.

we analyzed expression of TLR4 in previously published singlecell RNA-seq data sets generated from nondiseased human lungs
(29–31) (Supplemental Figure 4). Expression of TLR4 was largely
restricted to FABP4-positive TRAMs, although some endothelial cells and monocytes also demonstrated expression of TLR4.
Given that endothelial cells face the vasculature and monocytes
in human lungs are largely retained in the blood vessels (13, 32),
TRAMs are likely to be the predominant secretors of CXCL2 in
response to TLR4 stimulation by LPS present in the alveolar space.
Nevertheless, to confirm that TRAMs drive neutrophil recruitment in response to LPS, we administered clodronate-loaded
liposomes intratracheally to selectively deplete TRAMs in WT
mice (Supplemental Figure 5). Depletion of TRAMs before LPS
challenge in WT mice resulted in a significant decrease in CXCL2
levels in BALF (Figure 3A) along with a significant reduction in
neutrophil infiltration in lung tissue, determined by flow cytometry (Figure 3B) and 2-photon microscopy (Figure 3, C and D; and
Supplemental Videos 1 and 2). Next, to determine whether CXCL2
signaling was necessary for neutrophil recruitment in response to
LPS, we treated mice with anti-CXCL2 antibodies (13). Neutralization of CXCL2 resulted in a significant attenuation of neutrophil
recruitment to the injured lungs, 24 hours after LPS administration (Figure 3E). Similarly, mice deficient in the CXCL2 receptor
(Cxcr2–/–) did not develop neutrophil influx in response to i.t. LPS
(Figure 3F). Moreover, depletion of circulating CMs using anti-

CCR2 antibody (Supplemental Figure 6, A–C), NCMs using intravenously administered Clo-lip (Supplemental Figure 6, D–F), or
simultaneous depletion of monocytes, peribronchial interstitial
macrophages, and lung CD11b+ dendritic cells using CD11b-DTR
system, had no effect on neutrophil trafficking in response to i.t.
LPS (Supplemental Figure 6, G and H). Taken together, these data
demonstrate that TRAMs are responsible for neutrophil influx in
response to LPS through the production of CXCL2.
Donor TRAMs exacerbate PGD in donor lung containing endotoxin
through the production of CXCL2. We have recently shown that
donor origin pulmonary intravascular NCMs recruit neutrophils
following transplant and contribute to the pathogenesis of PGD in
a mouse model of lung transplantation (12, 13). As bacterial infections are common in human donor lungs, we investigated whether
NCMs, TRAMs, or both would mediate neutrophil recruitment in
donor lungs exposed to LPS. Accordingly, we treated donors with
a low dose of LPS (0.5 μg/g BW), insufficient to cause donor lung
injury, and found that while LPS-free donor lungs from mice lacking NCMs (Nr4a1–/–) did not develop neutrophil recruitment and
PGD following lung transplantation (13), in contrast, donor lungs
from low-dose LPS-treated Nr4a1–/– mice did (Figure 4, A and B).
Similarly, pharmacological depletion of donor NCMs using i.v.
Clo-lip prevented neutrophil recruitment following murine lung
transplant of LPS-free (13), but not of LPS-containing, donor lungs
(Figure 4, A and B), suggesting that neutrophil recruitment associjci.org   Volume 130   Number 8   August 2020
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Figure 4. Influx of recipient neutrophils into the allograft containing LPS is abrogated by depletion of donor TRAMs and is CXCL2 dependent. (A)
Diagram depicting experiment shown in B. WT C57BL/6 mice received BALB/c allogeneic donor lungs containing low-dose LPS (0.5 μg/g BW) injected i.t.,
insufficient to cause native lung injury. To deplete NCMs, donors were treated with i.v. Clo-lip before i.t. LPS. To deplete both donor monocytes and donor
TRAMs, we treated the donors with i.v. Clo-lip and i.t. Clo-lip, respectively, before i.t. LPS. Next, we used Nr4a1–/– donor lungs containing low-dose LPS and
transplanted them into WT recipients after depletion of TRAMs using i.t. Clo-lip, or using PBS-lip as control. Last, to determine whether CXCL2 secretion
by donor TRAMs led to neutrophil recruitment, we treated recipients of Nr4a1–/– donor lungs containing low-dose LPS with anti-CXCL2 antibodies at the
time of transplantation. Additionally, we transplanted Nr4a1–/– donor lungs containing low-dose LPS into Cxcr2–/– recipients and determined neutrophil
infiltration at 24 hours.(B) Quantification of neutrophil infiltration into lungs after these treatments was performed using flow cytometry (n = 4–5). (C)
CXCL2 chemokine levels in BALF of recipient mice after receiving low-dose LPS-treated Nr4a1–/– donor lungs compared with PBS-treated Nr4a1–/– donor
lungs (n = 5). (D) TRAMs were isolated from endotoxin-negative and endotoxin-positive human donor lungs at 120 minutes after reperfusion and analyzed
for CXCL2 transcription (n = 4). All graphs show mean ± SD. Graph in B was analyzed by 1-way ANOVA followed by Tukey’s post hoc test. Graphs in C and D
were analyzed by unpaired t test. ***P < 0.01; ****P < 0.0001. CT, control.

ated with LPS in donor lungs is NCM independent. On the other
hand, depletion of TRAMs in LPS-treated Nr4a1–/– donor lungs
before transplant using i.t. Clo-lip or depletion of both TRAMs
and NCMs by i.t. plus i.v. Clo-lip in WT donor lungs attenuated the
LPS-induced neutrophil infiltration (Figure 4, A and B).
We have reported that Nr4a1–/– donor lungs have reduced
CXCL2 levels following transplant when compared with WT donor
lungs (13). However, administration of low-dose LPS to Nr4a1–/–
donor lungs before transplantation resulted in increased CXCL2
levels (Figure 4C). We also found increased CXCL2 mRNA expression in TRAMs isolated from human donor lungs positive for endotoxin compared with those negative for endotoxin following transplantation reperfusion (Figure 4D). To determine whether CXCL2
was necessary for the recruitment of neutrophils in endotoxin4460
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containing donor lungs, we treated recipients with an anti-CXCL2
antibody immediately after transplantation or used Cxcr2–/– mice
as transplant recipients. In both cases, neutrophil recruitment
after transplantation of the endotoxin-containing donor lung was
attenuated (Figure 4, A and B). Collectively, these results show that
ischemia/reperfusion-primed TRAMs can recruit neutrophils in
lung allografts containing low levels of endotoxin through CXCL2
release, obviating the requirement for NCMs.
TRAM-mediated neutrophil recruitment in response to endotoxin
is dependent on TLR4-MyD88 signaling. The pattern recognition
receptor for LPS is toll-receptor 4 (TLR4), which interacts with the
intracellular adaptor protein MyD88 to enable signal transduction
(33). In order to test whether the TLR4-MyD88 signaling pathway
was responsible for the LPS priming of TRAMs before lung trans-
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Figure 5. TLR4-MyD88 signaling
directs TRAM-mediated neutrophil
recruitment. (A) Flow cytometry
quantification of TRAMs in WT and
Cd11cCreMyd88Δ mice (n = 5–7). TRAMs
were gated as live CD45+Ly6G–NK1.1–
SiglecF+CD64+ cells. (B) Flow cytometry quantification of neutrophil
(live CD45+Ly6G+CD11b+CD24+SSChi
cells) infiltration into lungs after i.t.
LPS (2 μg/g BW) in Cd11cCreMyd88Δ
compared with control WT mice (n
= 6). (C) Diagram depicting TRAM
reconstitution experiment shown in
D. (D) Flow cytometry quantification
of neutrophil infiltration into lungs
determined as in B after i.t. LPS (2
μg/g BW) in Cd11cCreMyd88Δ mice
reconstituted with WT (WT TRAM)
or Tlr4–/– TRAMs (Tlr4.KO TRAM)
compared with Cd11cCreMyd88Δ mice
(n = 5–6). All graphs show mean ± SD.
(A and B) Graphs were analyzed
by unpaired t test. (C) Graph was
analyzed by 1-way ANOVA followed
by Tukey’s post hoc test. *P = 0.05;
****P < 0.0001.

plantation, we crossed Cd11cCre transgenic mice with Myd88fl/fl
(Myd88Δ) mice to generate Cd11cCreMyd88Δ mice, which lack MyD88
expression specifically in TRAMs and DCs. Cd11cCreMyd88Δ mice
had similar numbers of TRAMs compared with WT mice (Figure
5A); however, they showed an attenuated neutrophil infiltration
to the lungs in response to LPS (Figure 5B). We then performed a
rescue experiment in which we treated the Cd11cCre-Myd88Δ mice
with i.t. liposomal clodronate to deplete TRAMs lacking MyD88
expression, and then adoptively transferred TRAMs from WT or
Tlr4 –/– mice. As shown in Figure 5, C and D, reconstitution with
WT TRAMs restored neutrophil infiltration, whereas reconstitution with TRAMs lacking TLR4 expression showed no difference in
neutrophil recruitment compared with Cd11cCreMyd88Δ mice. This
indicated that the neutrophil recruitment by TRAMs in response to
LPS is dependent on TLR4-MyD88 signaling.
Lung transplant ischemia/reperfusion activates TRAMs to
increase CXCL2 production in response to endotoxin via TLR4 regulation. Human TRAMs isolated from donor lungs containing endotoxin produced increased amounts of CXCL2 following reperfusion compared with TRAMs isolated from endotoxin-free human
lungs (Figure 6A). Moreover, ischemia/reperfusion-primed
human donor TRAMs produced more CXCL2 in vitro in response
to the same amount of endotoxin compared with their native state
(Figure 6B and Supplemental Figure 7). Therefore, we explored
the role of ischemia/reperfusion in priming TRAMs to endotoxin
using murine models. Similar to humans, TRAMs isolated from
murine donor lungs after ischemia produced significantly more

CXCL2 upon stimulation with LPS (Figure 6, C and D). We next
performed RNA-Seq analysis of donor TRAMs experiencing
ischemia/reperfusion injury (13, 34), which revealed upregulation
of TLR4 and its coreceptor CD14 (Figure 7A). We validated these
findings by performing quantitative real-time PCR of TRAMs
isolated from murine donor lungs before and after ischemia
(Figure 7B). To understand TLR4 regulation during ischemia/
reperfusion injury, we performed a time course after ischemia,
analyzing both Tlr4 mRNA levels and protein expression at the
plasma membrane in TRAMs. We found that Tlr4 mRNA levels
started increasing 4 hours after ischemia, reaching significance
at 24 hours (Figure 7C). Using flow cytometry, we determined
that TLR4 protein expression at the plasma membrane reached
statistical significance at 4 hours after ischemia, keeping a constant expression at 24 hours (Figure 7D). Moreover, immunocytochemistry (ICC) performed in donor TRAMs isolated at serial
time points following transplantation showed that TLR4 increasingly accumulated toward the cell periphery following transplantation (Figure 7E, Supplemental Figure 8 and Supplemental
Figure 9). These results suggest that ischemia/reperfusion injury
induces TLR4 translocation to the plasma membrane at earlier
time points (35), followed by increased de novo synthesis at
later time points. Finally, to determine whether TLR4 signaling is
necessary for LPS-induced activation of donor lung TRAMs, we
administered LPS in the presence of TLR4 antagonist (TAK-242)
or CD14/TLR4 antagonist (IAXO-101) and then transplanted
these lungs into WT recipients. We found that anti-TLR4 treatjci.org   Volume 130   Number 8   August 2020
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biopsies obtained from the donor lung that
sustained warm ischemia during implantation but immediately before reperfusion; (d)
30 minutes after reperfusion; and (e) 120
minutes after reperfusion. We found that
ROS increased during the warm-ischemia
phase and continued to increase at 30 and
120 minutes after reperfusion (Figure 8A).
Intriguingly, TLR4 transcription in human
donor TRAMs did not increase until 30
minutes after reperfusion but continued to
increase at the 120-minute time point (Figure 8A). It was clinically infeasible to evaluate TRAMs from the donor lung tissue site
at longer time points since the chest of the
recipient is closed at the conclusion of the
surgical procedure. Accordingly, we performed experiments using exogenous ROS to
replicate these findings. We cultured murine
TRAMs in the presence of 100 μM hydrogen
peroxide, as previously described (35). At 1
hour, we did not observe any change in Tlr4
transcription, but its translocation to the cell
membrane increased significantly (Supplemental Figure 10, A and B). Unfortunately,
we could not evaluate the effects of hydrogen peroxide on TRAMs in vitro beyond 1
hour, as we observed progressive cell death
at longer time points (Supplemental Figure
10C). Nevertheless, using the murine model
of lung transplantation, we could confirm a
role for mitochondrial ROS by using the genFigure 6. Ischemia/reperfusion-primed TRAMs have augmented response to endotoxin. (A)
eral ROS scavenger N-acetylcysteine (NAC)
Relative CXCL2 mRNA levels of human TRAMs from endotoxin-negative and endotoxin-positive
(38), and the mitochondrial ROS scavenpatients before and after reperfusion (n = 6). (B) Fresh TRAMs from endotoxin-negative human
gers Mito-Tempo (MT) (39) and dimethyl
donor lungs were isolated before transplantation or 120 minutes after reperfusion and then stimmalonate (DM) (40) to abrogate the ischulated with endotoxin in vitro (0.01 μg/mL LPS) (n = 10). (C) Diagram depicting the experiments
emia/reperfusion-induced increase in Tlr4
illustrated in D, where TRAMs harvested before and after ischemia were challenged with LPS in
vitro. (D) CXCL2 chemokine levels in the supernatant of murine TRAMs harvested before and after
transcription and expression at the plasma
ischemia and challenged in vitro with LPS (0.01 μg/mL) for 4 hours (n = 3–4). (A–C) Graphs were
membrane. Indeed, donor TRAMs did not
analyzed by unpaired t test. *P < 0.05; **P < 0.01; ****P < 0.0001.
develop an increase in Tlr4 transcription or
TLR4 protein translocation to the plasma
membrane following murine lung transplantation when treated with NAC, MT, or DM as demonstrated by
ment suppressed the neutrophil influx after transplant associated
both qualitative and quantitative measures (Figure 8, B–D). Morewith LPS (Figure 7F).
over, NAC treatment prevented neutrophil recruitment and develROS released during warm ischemia and following reperfusion
opment of PGD in endotoxin-containing Nr4a1–/– donor lungs
increased the transcription of TLR4 and its translocation to the cell
membrane in TRAMs. ROS generated in the mitochondria have
(Figure 8, E and F).
been implicated in signaling pathways activated after ischemia/
reperfusion injury (36, 37). To explore whether ROS are necesDiscussion
sary for the increased transcription of TLR4 in donor TRAMs, we
Despite the increasing numbers of lung transplants worldwide,
analyzed ROS generation in donor human lung tissue and TLR4
there is a significant gap between the demand and availability of
mRNA expression in TRAMs at 5 consecutive time points during
lungs for transplants (41). Many potential donor lungs with adeischemia/reperfusion. Donor tissue was harvested as follows: (a)
quately treated donor pneumonias are turned down at the time of
in situ native lung: biopsies obtained after opening donor’s chest
evaluation because of concerns for the development of PGD folcavity and before procurement; (b) end of cold ischemia: biopsies
lowing transplantation (42–44). While neutrophil recruitment into
obtained after the donor lung was removed from cold-storage
the transplanted lung allograft is essential for the development
but before initiation of implantation; (c) end of warm ischemia:
of PGD, a lack of insight into mechanisms that drive neutrophils
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Figure 7. TRAMs exposed to ischemia/reperfusion have increased TLR4 transcription and translocation to the plasma membrane. (A) Heatmap of
selected TLR4 pathway genes expressed in murine donor TRAMs exposed to ischemia/reperfusion (n = 3–5). (B) Tlr4 and Cd14 mRNA expression in TRAMs
harvested from BALF before and after ischemia at 24 hours was assessed by qPCR (n = 3). (C) Expression level of Tlr4 mRNA in TRAMs harvested from
BALF before ischemia and 1 hour, 4 hours, and 24 hours after ischemia, assessed by qPCR (n = 3–5). (D) Protein expression of TLR4 at the plasma membrane in TRAMs harvested as in C, assessed by flow cytometry (n = 3–5). (E) Immunocytochemistry for TLR4 of TRAMs harvested as described in C. (F) WT
C57BL/6 donor mice were treated with low-dose i.t. LPS (0.5 μg/g BW) alone or in combination with TLR4 antagonist (TAK-242; 1 μg/g BW, i.v.) or IAXO-101
(3 μg/g BW, i.t.) and neutrophil recruitment was assessed 24 hours after ischemia. Neutrophils were gated as live CD45+Ly6G+CD11b+CD24+SSChi cells (n =
4–5). (B) Graph was analyzed by unpaired t test. (C, D, and F) Graphs were analyzed by 1-way ANOVA followed by Tukey’s post hoc test. *P < 0.05; **P <
0.01; ***P < 0.001; ****P < 0.0001. Scale bar: 10 μm. Arrow points to TLR4 at the plasma membrane.

into the allograft has precluded therapies targeted to the donor or
recipient that might attenuate their recruitment and the attendant
lung injury. We found that human donor lungs successfully treated
for bacterial pneumonia had residual endotoxin despite the clearance of bacterial pathogen. In a mouse lung transplant model, levels of endotoxin insufficient to induce detectable injury in donor
lungs was associated with increased neutrophil recruitment as
well as physiological markers of allograft injury. This is consistent
with the observed association between historic pneumonia in the
donor lung and PGD (44).
We used a mouse model of lung transplant to elucidate the
mechanisms by which a low level of LPS in the donor lung induces
neutrophil recruitment into the allograft. We found that endotoxin
in the donor lung primes donor TRAMs to release CXCL2 after lung
transplantation, leading to neutrophil recruitment. We also found
that ischemia reperfusion injury upregulates both TLR4 and CD14

on TRAMs, potentially creating a feed-forward loop to sustain neutrophil recruitment. The importance of LPS/TLR4/MyD88 signaling in TRAMs was confirmed by using genetic and pharmacologic
inhibitors combined with cell-specific depletion and reconstitution
studies. In marked contrast to the requirement of NCMs for neutrophil recruitment into allografts from naive donors (13), TRAMs
in the donor lung were indispensable and NCMs were dispensable
for neutrophil recruitment in LPS-contaminated donors. These
findings show that the exposure history in the donor can reshape
neutrophil responses during lung transplantation.
Release of ROS during ischemia/reperfusion injury contributes to the pathogenesis of organ dysfunction (37). We analyzed
human donor lungs longitudinally to evaluate for the production
of ROS. We found that ROS started to increase during the warmischemia phase and continue to do so following reperfusion, but the
increase in TLR4 transcription was not observed until 30 minutes
jci.org   Volume 130   Number 8   August 2020
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Figure 8. ROS produced during ischemia reperfusion are responsible for TLR4 upregulation. (A) Human donor lungs being used for clinical transplantation were serially biopsied during the different phases of ischemia/reperfusion and development of ROS, and TLR4 transcription of flow-sorted donor
TRAMs was determined. (B) WT BALB/c mice were transplanted with WT C57BL/6 donor lungs. In order to test the effect of ROS on TLR4 expression in
TRAMs, we treated donors and recipient with NAC (100 mg/kg BW), MT (5 mg/kg BW, i.p.), or DM (10 mg/kg BW, i.v.), before and after reperfusion. Tlr4
mRNA levels were assessed 24 hours after ischemia by qPCR in TRAMs harvested from BALF before and after transplantation (n = 3–5). (C) Protein expression of TLR4 at the plasma membrane in TRAMs harvested as in B, assessed by flow cytometry (n = 4). (D) Immunocytochemistry for TLR4 of TRAMs
harvested as described in B. Nr4a1–/– donor lungs, which do not develop PGD, were administered low-dose LPS and transplanted into WT recipients with or
without NAC treatment. (E) Neutrophil infiltration was determined using flow cytometry and (F) lung function was determined using blood gases and P/F
ratio. (B, C) Graphs were analyzed by 1-way ANOVA followed by Tukey’s post hoc test. (E, F) Graphs were analyzed by unpaired t test. *P < 0.05; ## and **P
< 0.01; ### and ***P < 0.001; ****P < 0.0001. (A) *ROS; #TLR4 transcription. Scale bar: 10 μm. Arrow points to TLR4 at the plasma membrane.

after reperfusion (45). As warm ischemia lasts 45 to 60 minutes, we
concluded that the increase in TLR4 transcription lags generation
of ROS by 1 to 2 hours. We confirmed these findings in the murine
lung transplant model where the expression of TLR4 increased
after transplant and were inhibited using the general ROS scavenger N-acetylcysteine (NAC) (46) as well as the mitochondrial
ROS scavengers Mito-Tempo (MT) (39) and dimethyl malonate
(DM) (40). Further work is needed to determine the mechanisms
by which ROS augment Tlr4 and Cd14 transcription and whether
ischemia reperfusion driven ROS also augment TLR4 translocation to the plasma membrane via Src-dependent signaling through
generation of ceramide as has been described (35, 47).
Our findings provide a mechanistic explanation for the marked
and unpredictable heterogeneity between transplant recipients in
the incidence and severity of PGD with implications for therapy.
Specifically, we found that both primed alveolar macrophages
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from LPS treated donors and NCMs responded to lung transplant
mediated ischemia reperfusion injury by releasing CXCL2, also
known as MIP-2 (13, 48). While other cytokines and chemokines
play a role in the initiation and propagation of the inflammatory
response, the focus of our work was on neutrophil recruitment.
Our focus on CXCL2 was justified based on our prior publication
(13) which revealed a nonredundant role of CXCL2 in neutrophil
recruitment to the allograft following lung transplantation and
supported by our analysis of several other cytokines in LPS containing donor lungs (Supplemental Figure 1). Causal evidence
comes from the murine transplant model where genetic or pharmacological neutralization of CXCL2 in the LPS primed donor
lung reduced neutrophil recruitment. Furthermore, we found that
inhibition of mitochondrial ROS, which have been implicated in
signaling pathways induced by ischemia reperfusion injury (36,
37), attenuated CXCL2 mediated neutrophil recruitment after
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lung transplantation. While removing LPS from donor lungs is
unlikely to be feasible, treatment of donor lungs with a history
of pneumonia with these inhibitors before transplantation might
safely reduce the risk of PGD and expand the pool of lungs available for transplantation. Importantly, we were able to confirm
key aspects of our murine model in homologous cell populations
isolated from patients with severe pneumonia in our intensive
care unit and in patients undergoing lung transplantation in our
center. More careful phenotyping of the exposure history in the
donor lung might reveal additional environmental exposures that
drive PGD. Putative exposures can be causally examined in preclinical murine lung transplant models as we show in this study.
While our data using bone marrow chimeric mice combined with
scRNA-Seq data implicated TRAMs as the predominant cell type
necessary for the production of CXCL2, a role for another cell type
in the donor lung releasing CXCL2 should be recognized since it
has been shown that alveolar epithelial cells can produce CXCL2
in response to pathogens (49). Additionally, while the focus of
our study was on neutrophil recruitment that was dependent on
CXCL2, it should be emphasized that other cytokines and chemokines would be necessary for the propagation of downstream
inflammatory cascade and need to be further elucidated.
Fulminant bacterial infections or high levels of endotoxin
will likely lead to severe injury to the donor lungs, making them
unsuitable for clinical transplantation. Our rationale for using low
levels of endotoxin was to specifically test the hypothesis that
residual PAMPs, which persist after treatment of donor pneumonias and are insufficient to cause injury in the native lungs,
can drive the pathogenesis of PGD. We recognize that damageassociated molecular patterns (DAMPs), such as HMGB1, might
be released during the ischemia/reperfusion phase and trigger
TLR4 activation (50, 51). While we tested the role of endotoxin
in this study, it is possible that these DAMPs may also contribute
to the clinical heterogeneity observed in the incidence of PGD.
Hence their role should be explored in future studies. Our current
and previously published data suggest the development of PGD
involves several cell populations including NCMs, neutrophils,
alveolar macrophages, and CMs. The complex signaling pathways leading to their orchestrated sequential recruitment and
activation are incompletely understood. Additionally, whether
compartmental separation of these DAMPs and PAMPs can selectively activate donor NCMs or TRAMs should also be explored. It
is intriguing that NCMs play a role in neutrophil recruitment in
response to DAMPs while recipient CMs permeabilize the pulmonary endothelium to promote neutrophil extravasation (11–13, 15).
In contrast, we found that donor TRAMs are capable of driving
both neutrophil recruitment as well as neutrophil extravasation
since depletion of TRAMs resulted in a marked decrease in both.
Whether TRAMs mediate neutrophil extravasation through the
recruitment of recipient classical monocytes remains unknown.
Future studies might examine the role of TRAMs in monocyte
trafficking to the lung allografts as they might introduce common
therapeutic targets to ameliorate both ischemia/reperfusion and
endotoxin-associated lung allograft injury.
Our study suggests several avenues for future investigation.
While the data using bone marrow chimeric mice combined with
scRNA-Seq data implicated TRAMs as the predominant cell type

necessary for the production of CXCL2, it has been shown that
alveolar epithelial cells can also produce CXCL2 in response to
pathogens (49). Additionally, we focused on neutrophil recruitment mediated by CXCL2 as it is the earliest event in the development of PGD. However, our current and previously published
data suggest that the development of PGD involves several cell
populations including NCMs, neutrophils, alveolar macrophages,
and CMs. The complex signaling pathways leading to their orchestrated sequential recruitment and activation are incompletely
understood. While we show a clear role for retained endotoxin
from different bacterial pathogens in neutrophil recruitment after
transplant, our findings do not exclude the possibility that DAMPs,
such as HMGB1, might be released during the ischemia/reperfusion phase and also trigger TLR activation (50, 51). Finally, the
lung microbiome did not reveal significant differences between
the pathogenic and nonpathogenic bacteria, making it less likely
to account for PGD outcomes. Furthermore, these organisms
would likely be cleared by the broad-spectrum antibiotics that
are administered routinely to the donor before transplant and the
recipient after transplant.
In conclusion, we show that contamination of donor lungs
with levels of LPS insufficient to induce detectable injury before
transplantation induces TLR4/MyD88 signaling in ischemia/
reperfusion-primed TRAMs to release CXCL2, leading to neutrophil recruitment. This priming of donor TRAMs is independent of
the requirement for NCMs to recruit neutrophils to lung allografts
from naive donors after lung transplantation. Our results highlight
the potential utility of strategies targeting CXCL2, scavenging
ROS, or blocking TLR4 or coreceptor CD14 on donor TRAMs and
NCMs to reduce neutrophil recruitment and PGD in endotoxin-containing donor lungs.

Methods
Human samples
Transplant patients. Bronchoscopic bronchoalveolar lavage and lung
biopsies were used to collect donor TRAMs at the different time points
outlined in the experiments.
P. aeruginosa–infected patients. Small aliquots (1–4 mL) of nonbronchoscopic bronchoalveolar lavage (NBBAL) fluid were collected from
patients with suspected infection (16).
BALF processing. Fluid was filtered through a 40-μm nylon cell
strainer and following staining, cells were sorted at the Northwestern University Robert H. Lurie Comprehensive Cancer Center Flow
Cytometry Core facility using FACSARIA III (BD Bioscience). TRAMs
were identified using sequential gating as singlets/CD45+/live/CD15 –/
CD206++/CD169+/HLA-DR+/high autofluorescence+ as previously
described (16).
Mice and procedures
WT C57BL/6J (B6), B6.FVB-Tg(ITGAMDTR/EGFP)-34Lan/J
(CD11b-DTR), and Rag –/– IL2g –/– mice with transgenes for human
GM-CSF and IL-3 (MISTRG mice) (16), Cxcr2–/–, and Nr4a1 –/– mice
were obtained from the Jackson Laboratory. Tlr4 –/– and Cd11c Cre
Myd88Δ mice in B6 background were a gift from Harris Perlman
(Department of Medicine, Northwestern University, Chicago) and
B6 lysozyme M (LysM)–GFP mice were originally obtained from
jci.org   Volume 130   Number 8   August 2020
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Table 1. Antibodies used for flow cytometry and sorting
Antigen

Clone

Fluorochrome

Manufacturer

CD24

M1/69

BUV395/APC

BD Horizon

CD45
CD11b
I-A/I-E
Ly6C

30-F11
M1/70
M5/114.15.2
HK 1.4

FITC/APC
FITC/APCCy7
FITC/PercpCy5.5
eFluor450

BioLegend
BD Horizon/BioLegend
BioLegend
eBioscience

Ly6G

1A8

AlexaFluor 700

BioLegend

NK1.1
CD64
SiglecF
CD11c

PK136
X54-5/7.1
E50-2440
HL3

AlexaFluor 700
PE
PECF594
PECy7

BD Biosciences
BioLegend
BD Biosciences
BD Biosciences

TLR4

MT5510

PECy7

BioLegend

Klaus Ley (La Jolla Institute for Immunology). All mice were maintained in a specific pathogen–free facility at the Center for Comparative Medicine at Northwestern University and used for the
described experiments at the age of 9 to 14 weeks and between 24
and 28 g body weight.
LPS induced lung injury. LPS from E. coli (serotype O111:B4; MilliporeSigma), P. aeruginosa 10 (serotype 10.22; MilliporeSigma), and
Klebsiella pneumoniae (source strain ATCC 15380; MilliporeSigma)
were used at 2 μg/g BW (body weight) or 0.5 μg/g BW (E. coli) and
0.2 μg/g BW P. aeruginosa and K. pneumoniae diluted in 50 μL PBS
and instilled i.t. MISTRG mice reconstitution and mouse pneumonia
model were previously described (16).
Broncho alveolar lavage fluid. BALF was obtained by instilling
lung airways 5 times with 0.5 mL PBS. BALF was centrifuged and the
supernatant was used for chemokine and cytokine determination as
described below.
Purified anti-CXCL2 (clone 40605; R&D Systems) or rat IgG2B
isotype control (R&D Systems), TAK-242, TLR4 antagonist (AbMole),
IAXO-101, CD14/TLR4 antagonist (Innaxon), NAC (MilliporeSigma), MT (MilliporeSigma), and DM (MilliporeSigma) were commercially acquired. Anti-CXCL2 antibodies or isotype control (200
μg/ms, i.v.), TAK-242 (1 μg/g BW, i.v.), and IAXO-101 (3 μg/g BW, i.t.)
were administrated to the donors 30 minutes before i.t. LPS (52, 53).
For ROS scavenger experiments, donor mice were treated with the
first dose of the NAC (100 mg/kg BW, i.v.), MT (5 mg/kg/ms, i.p.), or
DM (10 mg/kg BW, i.v.) 1 hour before transplant; then, recipient mice
received same doses of ROS scavenger 5 minutes before reperfusion 1
hour (NAC) or 2 hours (TM and DM) after reperfusion.
Mouse lung transplant with and without LPS. Orthotopic murine
left lung transplantation was performed as previously described (13).
Briefly, a donor mouse was anesthetized with a mixture of xylazine
(10 mg/ kg) and ketamine (100 mg/kg). Donor lungs were flushed
through the pulmonary artery with 3 mL saline solution and the heartlung block was excised and kept in cooled (4°C) preservative solution. The bronchus, pulmonary vein, and artery were dissected and
prepared for anastomosis. A customized cuff made of a Teflon intravenous catheter was applied to the vascular structures and fixated
with a 10-0 nylon ligature. After placement of a microvessel clip on
the bronchus to avoid airway infiltration with preservative solution,
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the graft was stored at 4°C for a period of 90–120 minutes of coldischemic time before implantation. The recipient mouse received
subcutaneous buprenorphine (0.1 mg/kg) 30 minutes before the thoracic surgical incision and every 6 hours as needed after the transplant procedure. The recipient mouse was intubated and a left-sided
thoracotomy was performed within the third intercostal space. The
recipient’s native lung was gently clamped and pulled out of the thoracic cavity. The space between the artery, the vein, and the bronchus was dissected separately. The artery and vein were temporarily
occluded using 8-0 nylon ligatures. The anastomoses were completed
by fixating each cuff with 10-0 nylon ligatures. The 8-0 ligatures were
released (first vein, then artery) and the lung inflated. The chest incision was closed and recipients separated from the ventilator when
spontaneous respiration resumed. No antibiotics or immunosuppressive agents were used postoperatively in any groups. For LPS-treated
donors with or without TLR4 or CD14 antagonist, we treated donor
mice 30 minutes before procurement with 0.5 μg/g/BW i.t. LPS with
or without 100 μg/ms/i.v., respectively.
Adoptive transfer of TRAMs. A tracheostomy was performed in the
donor mice to harvest TRAMs from BALF. Briefly, BALF was obtained
with 2 mM EDTA solution in PBS lavage following by centrifugation
and red blood cell (RBC) lysis. TRAMs obtained from BAL were resuspended in the final volume for adoptive transfer to the recipient mice
5 × 105 per recipient.
TRAM and monocyte depletion. Clodronate-loaded liposomes
and control phosphate-buffered saline liposomes were purchased
from Clodronateliposomes.com. At specific time points, mice were
injected i.t. (50 μL) or i.v. (200 μL) with clodronate-loaded liposomes or control PBS-loaded liposomes to deplete macrophages
or Ly6Chi monocytes, respectively (54). Cytotoxic anti-CCR2 antibodies were a gift of Steffen Jung (Weizmann Institute of Science,
Rehovot, Israel) and used for selective depletion of CCR2+ classical
monocytes as previously described. Diphtheria toxin (List Biologic
Laboratories, Inc.) was dissolved in 100 μL PBS and administered
i.p. to CD11b-DTR mice 24 hours before LPS administration to systematically deplete CD11b-expressing cells.

Compartmental lung intravenous staining for neutrophils
extravasation
Intravenous and intratracheal procedures were performed using
an adaptation of previously described methods (34). Briefly, 6 μg
APC-conjugated anti-CD45 in 100 μL sterile PBS was injected i.v. and
allowed to circulate for 3 minutes before euthanasia with an overdose
of Euthasol (Virbac). Tracheostomy was performed. The vena cava was
transected and the right ventricle flushed with 10 mL HBSS to wash
unbound i.v. antibody.
Multicolor flow cytometry
Single-cell suspensions from the whole lung of the mouse were
obtained and murine lung cell staining performed as previously
described (32, 55). Table 1 shows all antibodies used. Fixed samples
were run on a custom LSRFortessa Cell Analyzer (BD Bioscience)
or BD FACS Symphony A5-Laser Analyzer for flow cytometry analysis at the Northwestern University Robert H. Lurie Comprehensive Cancer Center Flow Cytometry Core facility. Acquired data
were analyzed with FlowJo v10.6 (FlowJo). For TRAM sorting, lung
airways were lavaged 5 times with 0.5 mL PBS. BALF was cen-
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trifuged and the cell pellet was processed and prepared for flow
sorting using a FACSARIA 4-Laser Sorter at the Northwestern
University Robert H. Lurie Comprehensive Cancer Center Flow
Cytometry Core facility.

Wet/dry ratio
Weight ratio for pulmonary edema was measured by harvesting lungs
after reperfusion at defined experiments, weighed, and then placed at
54°C until a stable dry weight was achieved. The ratio of wet weight to
dry weight was calculated as an indicator of pulmonary edema.
Histology and H&E staining
For histological analyses, the whole lung was harvested and gently
flushed through the pulmonary artery with 3 mL saline. Paraformaldehyde (4%) was instilled into the trachea with a pressure of 10
cmH2O then fixed for 48 to 72 hours before being embedded in paraffin. The whole lung was serially sectioned and stained with H&E.
Pictures were acquired using a Nikon TE-2000-U microscope.
ELISA
Endotoxin (Thermo Fisher Scientific), CXCL1, CXCL2, CXCL10,
and TNF-α ELISA was performed using a commercially available kit
accordingly to the manufacturer’s instructions (R&D Systems).
Secondary transcriptomic analysis
RNA-sequencing. RNA isolation and sequencing procedures are
detailed in our previous manuscript (34). For all analyses, normalized
tables of counts were generated from raw counts using the EdgR package (version 3.18.1). Filtering for low counts was performed by excluding genes that have the expression from more than half of all the samples. Functional enrichment analysis with GO biological processes
was performed with GOrilla with the top 1000 genes upregulated in P.
aeruginosa positive samples for all clusters. Significantly upregulated
genes were used to identify the top biological processes (–log10 [P
value]). Heatmaps of pathway genes based on the top GO processes
were identified and hierarchical clustering was generated to show the
expression of these genes in naive, low, and high virulence samples for
MISTRG mice (16).
Reanalysis of single-cell RNA-Seq data sets. To assess expression pattern of TRL4 in human lung, we queried 3 recently published singlecell RNA-Seq data sets (29, 30, 31). Data and author’s annotations
were accessed from GSE122960 (29), tissuestabilitycellatlas.org (30),
and GSE135893 (31). Only nondiseased lungs (indicated as donor or
control) were used for analysis. Precomputed R objects were loaded
into Seurat 3.1.4 and expression of TLR4 was visualized using
FeaturePlot command.
Two-photon microscopy
A custom-built 2-photon microscope running ImageWarp acquisition software (A&B Software) was used for time-lapse imaging. Mice
were anesthetized with an i.p. injection of ketamine (50 mg/kg) and
xylazine (10 mg/kg) and maintained with administration of half
doses every hour through the imaging process. Mice were intubated
orotracheally and ventilated with room air at a rate of 120 breaths/
min and with a tidal volume of 0.5 mL. Left thoracotomy was performed to expose the left lung, and the lung was imaged using a custom-built chamber maintained at 37°C. VetBond ring was used to
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attach the lung tissue to the bottom of the cover glass without direct
pressure on the exposed lung. For time-lapse imaging of leukocyte
migration in the tissue parenchyma, we averaged 15 video-rate
frames (0.5 s/slice) during the acquisition to match the ventilator
rate and minimize movement artifacts. Each plane represents an
image of 220 × 240 μm in the x and y dimensions. To visualize blood
vessels, 20 μL of 655-nm nontargeted Quantum dots (Q-dots) in 100
μL PBS was injected i.v. before imaging. Two-photon excitation produces a second harmonic signal from collagen (56) around alveoli,
thus providing a useful landmark for the air spaces. Explanted tissue
was examined as described (56–58).

mRNA isolation and qPCR
Total RNA was extracted using miRNeasy Mini Kit (Qiagen). cDNA
was synthesized from 1 μg total RNA by using a qScript cDNA Synthesis kit (Quanta Biosciences) and mRNA expression was determined
by qPCR using iTaq Universal Probes Supermix (Bio-Rad). Relative
expression of the transcripts was determined according to the ΔΔCt
method using actin or RPL19 as reference for normalization. Primers
used were as follows: cxcl2-F, CCCAGACAGAAGTCATAGCCAC;
cxcl2-R, GCCTTGCCTTTGTTCAGTATC; tlr4-F, TGGCTGGTTTACACATCCATCGGT; tlr4-R, TGGCACCATTGAAGCTGAGGTCTA;
B-actin-F, CACCACACCTTCTACAATGA; B-actin-R, GTCTCAAACATGATCTGGGT.
Reactive oxygen species measurement
The ROS levels were examined in lung samples using a commercially
available assay (In Vitro OxiSelect Assay Kit, Cell Biolabs). Briefly, we homogenized the lung tissue obtained at the different time
points during the lung transplantation (native donor lung before
reperfusion, cold ischemia, warm ischemia, 30 minutes after reperfusion) according to the manufacturer’s recommendation and
resuspended it in the assay buffer. The cell-permeable fluorogenic
probe was then used to assess the ROS levels. Fluorescence was read
on a Spectramax plate reader.
Immunocytochemistry and fluorescence microscopy
We used cytospin to immobilize 10,000–50,000 TRAMs onto slides,
where cells were fixed with 4% formaldehyde, permeabilized with
0.5% Triton X-100, and immunostained with anti–PE-TLR4 antibody (BioLegend, clone HTA125). Nuclei were stained with Hoechst
33342 (MilliporeSigma). For immunocytochemistry, cells were
imaged using a Zeiss Axioplan 2 fluorescence microscope. Confocal
images were acquired using a Zeiss Axio Imager Z2 with ApoTome.2
microscope equipped with Axiocam 503 Mono, X-Cite 120 LED
Boost System, and Zen 2.3 software (Carl Zeiss).
Microbiome analysis
Ten BAL washings of donor lungs were obtained in the operating
room at the time of organ implantation. Rectal swabs were obtained
for 5 of these patients at the same time. Samples were immediately
centrifuged to collect cellular DNA and stored at –80° C. Samples then
underwent batched genomic DNA extraction, PCR amplification targeting the 16S ribosomal RNA gene, pooling, and high-throughput
sequencing with paired-end, 300-base reads on the Illumina MiSeq
platform to obtain overall taxonomic compositions of the microbial
communities. A sterile swab obtained just before DNA extraction
jci.org   Volume 130   Number 8   August 2020
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was used for the negative control. Distances for each sample’s overall microbial profile were generated via square root transformation of
the relative abundances of each taxon. A nonmetric multidimensional
scaling plot was created by using Bray-Curtis dissimilarity through
PRIMER version 7 as shown in Supplemental Figure 2. 2D stress was
0.14. An analysis of similarity (ANOSIM) was used to determine statistical similarities among groups.

TRAM viability in vitro
TRAM viability was measured with acridine orange/propidium
iodide (AO/PI) nucleic acid binding dyes method, using a Nexcelom
cellometer. AO is cell permeable; all stained nucleated cells generate a green fluorescence and PI only enters cells with compromised
membranes. Therefore, dying, dead, and necrotic nucleated cells
stained with PI generate a red fluorescence. Cell viability was calculated by examining the ratio of the number of live to the number of
dead fluorescing cells (Nexcelom).
Statistics
Data analysis was performed using Prism 8 (GraphPad Software).
Results are expressed as mean ± SD and the n values for each data set
are provided in the figure legends. Statistical significance was assessed
by 2-tailed Student’s t test or 1-way ANOVA followed by Tukey’s post
hoc test. A P value less than 0.05 was considered significant.
Study approval
All procedures were approved by The Institutional Animal Care
and Use Committee (IS00002248) at Northwestern University.
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for the Care and Use of Laboratory Animals (National Academies
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